Difference between revisions of "User:Groma"
| Line 6: | Line 6: | ||
|Phone=+34 93 316 01 81 | |Phone=+34 93 316 01 81 | ||
}} | }} | ||
| − | Guglielmo holds nine years of experience in bioinformatics in both Academic ([http://www.ceinge.unina.it/ CEINGE], [http://www.tigem.it/ TIGEM], currently [http://www.crg.cat/ CRG]) and Pharmaceutical environments ([http://www.merckserono.com/en/index.html MerckSerono International]). In this period, he has been involved in different aspects of bioinformatics, such as the discovery of novel transcripts expressed in ES cells [http://www.ncbi.nlm.nih.gov/pubmed/17540781], the development of biological resources and databases [http://www.ncbi.nlm.nih.gov/pubmed/19906694][http://www.ncbi.nlm.nih.gov/pubmed/17942430], the identification of disease genes using comparative genomics approaches [http://www.ncbi.nlm.nih.gov/pubmed/16174644] [http://sulfabase.tigem.it/], the discovery of gene regulatory networks (under review), the identification of clinical biomarkers (Phase Ia and Ib) through advanced data analysis approaches (in MerckSerono, data not published), among | + | Guglielmo holds nine years of experience in bioinformatics in both Academic ([http://www.ceinge.unina.it/ CEINGE], [http://www.tigem.it/ TIGEM], currently [http://www.crg.cat/ CRG]) and Pharmaceutical environments ([http://www.merckserono.com/en/index.html MerckSerono International]). In this period, he has been involved in different aspects of bioinformatics, such as the discovery of novel transcripts expressed in ES cells [http://www.ncbi.nlm.nih.gov/pubmed/17540781], the development of biological resources and databases [http://www.ncbi.nlm.nih.gov/pubmed/19906694][http://www.ncbi.nlm.nih.gov/pubmed/17942430], the identification of disease genes using comparative genomics approaches [http://www.ncbi.nlm.nih.gov/pubmed/16174644] [http://sulfabase.tigem.it/], the discovery of gene regulatory networks (under review), the identification of clinical biomarkers (Phase Ia and Ib) through advanced data analysis approaches (in MerckSerono, data not published), among others. He currently leads the CRG Bioinformatics Core Facility with the main goal to provide scientists, at CRG/PRBB and external institutions, with computational and data analysis expertise. |
Guglielmo Roma may be contacted at +34 933160181 or by e-mail at the address mailto:guglielmo.roma@crg.es. | Guglielmo Roma may be contacted at +34 933160181 or by e-mail at the address mailto:guglielmo.roma@crg.es. | ||
Revision as of 08:20, 3 September 2010
Guglielmo holds nine years of experience in bioinformatics in both Academic (CEINGE, TIGEM, currently CRG) and Pharmaceutical environments (MerckSerono International). In this period, he has been involved in different aspects of bioinformatics, such as the discovery of novel transcripts expressed in ES cells [1], the development of biological resources and databases [2][3], the identification of disease genes using comparative genomics approaches [4] [5], the discovery of gene regulatory networks (under review), the identification of clinical biomarkers (Phase Ia and Ib) through advanced data analysis approaches (in MerckSerono, data not published), among others. He currently leads the CRG Bioinformatics Core Facility with the main goal to provide scientists, at CRG/PRBB and external institutions, with computational and data analysis expertise.
Guglielmo Roma may be contacted at +34 933160181 or by e-mail at the address mailto:guglielmo.roma@crg.es.
